Cryptococcus neoformans can invade the central nervous system through diverse mechanisms. We examined a possible role for host plasma proteases in the neurotropic behaviour of this bloodborne fungal pathogen. Plasminogen is a plasma-enriched zymogen that can passively coat the surface of blood-borne pathogens and, upon conversion to the serine protease plasmin, facilitate pathogen dissemination by degrading vascular barriers. In this study, plasminogen-to-plasmin conversion on killed and viable hypoencapsulated strains of C. neoformans required the addition of plasminogen activator (PA), but this conversion occurred in the absence of supplemented PA when viable strains were cultured with brain microvascular endothelial cells (BMEC). Plasmincoated C. neoformans showed an enhanced invasive ability in Matrigel invasion assays that was significantly augmented in the presence of BMEC. The invasive effect of plasmin required viable pathogen and correlated with rapid declines in BMEC barrier function. Plasmin-enhanced invasion was inhibited by aprotinin, carboxypeptidase B, the lysine analogue epsilon-aminocaproic acid, and by capsule development. C. neoformans caused plasminogen-independent declines in BMEC barrier function that were associated with pathogen-induced host damage; however, such declines were significantly delayed and less extensive than those observed with plasmin-coated pathogen. BMEC adhesion and damage by hypoencapsulated C. neoformans were diminished by capsule induction but unaltered by plasminogen and/or PA. We conclude that hypoencapsulated C. neoformans can invade BMEC by a plasmin-dependent mechanism, in vitro, and that small, or minimal, surface capsule expression during the blood-borne phase of cryptococcosis may promote virulence by means of plasmin(ogen) acquisition.
INTRODUCTIONCryptococcus neoformans is an encapsulated fungus with a global distribution and is recognized as a major opportunistic pathogen (Bennett et al., 1977;Kwon-Chung & Bennett, 1984). C. neoformans has been grouped into two distinct serotypes (A and D) on the basis of capsule structure/antigenicity, with serotype A responsible for 95 % of the cryptococcal infections reported worldwide (Franzot et al., 1999;Idnurm et al., 2005). The onset of cryptococcosis is believed to occur following inhalation of either basidiospores or desiccated yeast (Kwon-Chung, 1992; Velagapudi et al., 2009). Both forms are optimally sized for alveolar deposition and pulmonary infection, which, if not controlled, can lead to the haematogenous spread of C. neoformans to the brain and other target organs.Blood-borne C. neoformans demonstrates a unique tropism for the central nervous system (CNS) that typically results in cryptococcal meningitis (Kovacs et al., 1985;Lee et al., 1996). The ability of C. neoformans to penetrate the bloodbrain barrier (BBB) by diverse and mutually independent mechanisms likely contributes to its tropism for the CNS. For example, both transcytosis (Chang et al., 2004;Chen et al., 2003) and a phagocytosis-mediated (Tr...